Friday, March 03, 2017 10:58:51 AM
$10 Billion Revenues - (NYSE)$VRX
Hmmmm.."Many Products & *Subsidiaries*" :
https://en.m.wikipedia.org/wiki/Valeant_Pharmaceuticals
"Valeant Pharmaceuticals International, Inc."
Public company NYSE: VRX TSX: VRX
S&P/TSX 60 component
Pharmaceutical industry Founded 1960
Headquarters Laval, Quebec, Canada
Key people
Joseph C. Papa (Chairman and CEO), Paul Herendeen (CFO), Milan Panic (Founder)
***Products***
Xifaxan
Uceris
Arestin
Jublia
Solodyn
Ziana
Acanya
Atralin
Retin-A Micro
Microsphere
Onexton
Elidel
Glumetza
Wellbutrin XL
Isuprel
Xenazine
Nitropress
Cuprimine
Targretin
Zovirax
Syprine
Revenue Decrease US$9.674 billion (2016)
Operating income
Decrease -US$0.566 billion (2016)
Net income
Decrease -US$2.409 billion (2016)
Total assets Decrease US$43.529 billion (2016)
Total equity Decrease US$3.152 billion (2016)
Number of employees
21,500 (2016)
***Subsidiaries***
Bausch & Lomb
Salix Pharmaceuticals
Medicis Pharmaceutical
Solta Medical
Dendreon
OraPharma
Obagi
Website: Valeant.com
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM